Global BCG and Tuberculosis Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global BCG and Tuberculosis Vaccine market size was valued at US$ 74 million in 2023. With growing demand in downstream market, the BCG and Tuberculosis Vaccine is forecast to a readjusted size of US$ 92 million by 2030 with a CAGR of 3.1% during review period.
The research report highlights the growth potential of the global BCG and Tuberculosis Vaccine market. BCG and Tuberculosis Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of BCG and Tuberculosis Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the BCG and Tuberculosis Vaccine market.
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guйrin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
The tuberculosis (TB) vaccination market is driven by the global efforts to combat TB and the increasing burden of the disease in high-risk populations. TB is a highly contagious bacterial infection that poses a significant public health challenge worldwide. Vaccination against TB, primarily through the Bacille Calmette-Guйrin (BCG) vaccine, is essential in reducing TB incidence and severity, especially in endemic regions. The rise in TB cases and drug-resistant strains contribute to market growth as governments and healthcare organizations focus on prevention strategies. Moreover, advancements in vaccine research and development, including novel TB vaccines under investigation, have the potential to further improve TB control efforts. However, the market also faces challenges, including the variable efficacy of the BCG vaccine against different forms of TB and the need for improved vaccine coverage in high-burden areas. Additionally, addressing vaccine supply and distribution challenges and ensuring equitable access to TB vaccination can pose obstacles for comprehensive disease control. To succeed, companies must focus on research and development to offer innovative TB vaccine candidates, collaborate with global health initiatives to promote vaccination campaigns, and address the challenges to meet the increasing demand for effective TB prevention solutions.
Key Features:
The report on BCG and Tuberculosis Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the BCG and Tuberculosis Vaccine market. It may include historical data, market segmentation by Type (e.g., Immune Vaccine, Therapy Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the BCG and Tuberculosis Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the BCG and Tuberculosis Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the BCG and Tuberculosis Vaccine industry. This include advancements in BCG and Tuberculosis Vaccine technology, BCG and Tuberculosis Vaccine new entrants, BCG and Tuberculosis Vaccine new investment, and other innovations that are shaping the future of BCG and Tuberculosis Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the BCG and Tuberculosis Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for BCG and Tuberculosis Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the BCG and Tuberculosis Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting BCG and Tuberculosis Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the BCG and Tuberculosis Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the BCG and Tuberculosis Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the BCG and Tuberculosis Vaccine market.
Market Segmentation:
BCG and Tuberculosis Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global BCG and Tuberculosis Vaccine market?
What factors are driving BCG and Tuberculosis Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do BCG and Tuberculosis Vaccine market opportunities vary by end market size?
How does BCG and Tuberculosis Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global BCG and Tuberculosis Vaccine market size was valued at US$ 74 million in 2023. With growing demand in downstream market, the BCG and Tuberculosis Vaccine is forecast to a readjusted size of US$ 92 million by 2030 with a CAGR of 3.1% during review period.
The research report highlights the growth potential of the global BCG and Tuberculosis Vaccine market. BCG and Tuberculosis Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of BCG and Tuberculosis Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the BCG and Tuberculosis Vaccine market.
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guйrin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
The tuberculosis (TB) vaccination market is driven by the global efforts to combat TB and the increasing burden of the disease in high-risk populations. TB is a highly contagious bacterial infection that poses a significant public health challenge worldwide. Vaccination against TB, primarily through the Bacille Calmette-Guйrin (BCG) vaccine, is essential in reducing TB incidence and severity, especially in endemic regions. The rise in TB cases and drug-resistant strains contribute to market growth as governments and healthcare organizations focus on prevention strategies. Moreover, advancements in vaccine research and development, including novel TB vaccines under investigation, have the potential to further improve TB control efforts. However, the market also faces challenges, including the variable efficacy of the BCG vaccine against different forms of TB and the need for improved vaccine coverage in high-burden areas. Additionally, addressing vaccine supply and distribution challenges and ensuring equitable access to TB vaccination can pose obstacles for comprehensive disease control. To succeed, companies must focus on research and development to offer innovative TB vaccine candidates, collaborate with global health initiatives to promote vaccination campaigns, and address the challenges to meet the increasing demand for effective TB prevention solutions.
Key Features:
The report on BCG and Tuberculosis Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the BCG and Tuberculosis Vaccine market. It may include historical data, market segmentation by Type (e.g., Immune Vaccine, Therapy Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the BCG and Tuberculosis Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the BCG and Tuberculosis Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the BCG and Tuberculosis Vaccine industry. This include advancements in BCG and Tuberculosis Vaccine technology, BCG and Tuberculosis Vaccine new entrants, BCG and Tuberculosis Vaccine new investment, and other innovations that are shaping the future of BCG and Tuberculosis Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the BCG and Tuberculosis Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for BCG and Tuberculosis Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the BCG and Tuberculosis Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting BCG and Tuberculosis Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the BCG and Tuberculosis Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the BCG and Tuberculosis Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the BCG and Tuberculosis Vaccine market.
Market Segmentation:
BCG and Tuberculosis Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Immune Vaccine
- Therapy Vaccine
- Self-Procurement
- UNICEF
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Japan BCG Lab
- Serum Institute of India
- AJ Vaccines
- BioFarma
- GreenSignal Bio Pharma
- China National Biotec
- Biomed Lublin
- Taj Pharmaceuticals
- Ataulpho de Paiva
- IVAC-Institute of Vaccines and Medical Biologicals
- Queen Saovabha Mem. Inst
- Microgen
What is the 10-year outlook for the global BCG and Tuberculosis Vaccine market?
What factors are driving BCG and Tuberculosis Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do BCG and Tuberculosis Vaccine market opportunities vary by end market size?
How does BCG and Tuberculosis Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global BCG and Tuberculosis Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for BCG and Tuberculosis Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for BCG and Tuberculosis Vaccine by Country/Region, 2019, 2023 & 2030
2.2 BCG and Tuberculosis Vaccine Segment by Type
2.2.1 Immune Vaccine
2.2.2 Therapy Vaccine
2.3 BCG and Tuberculosis Vaccine Sales by Type
2.3.1 Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global BCG and Tuberculosis Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global BCG and Tuberculosis Vaccine Sale Price by Type (2019-2024)
2.4 BCG and Tuberculosis Vaccine Segment by Application
2.4.1 Self-Procurement
2.4.2 UNICEF
2.4.3 Others
2.5 BCG and Tuberculosis Vaccine Sales by Application
2.5.1 Global BCG and Tuberculosis Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global BCG and Tuberculosis Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global BCG and Tuberculosis Vaccine Sale Price by Application (2019-2024)
3 GLOBAL BCG AND TUBERCULOSIS VACCINE BY COMPANY
3.1 Global BCG and Tuberculosis Vaccine Breakdown Data by Company
3.1.1 Global BCG and Tuberculosis Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global BCG and Tuberculosis Vaccine Sales Market Share by Company (2019-2024)
3.2 Global BCG and Tuberculosis Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global BCG and Tuberculosis Vaccine Revenue by Company (2019-2024)
3.2.2 Global BCG and Tuberculosis Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global BCG and Tuberculosis Vaccine Sale Price by Company
3.4 Key Manufacturers BCG and Tuberculosis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers BCG and Tuberculosis Vaccine Product Location Distribution
3.4.2 Players BCG and Tuberculosis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BCG AND TUBERCULOSIS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic BCG and Tuberculosis Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global BCG and Tuberculosis Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global BCG and Tuberculosis Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic BCG and Tuberculosis Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global BCG and Tuberculosis Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global BCG and Tuberculosis Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas BCG and Tuberculosis Vaccine Sales Growth
4.4 APAC BCG and Tuberculosis Vaccine Sales Growth
4.5 Europe BCG and Tuberculosis Vaccine Sales Growth
4.6 Middle East & Africa BCG and Tuberculosis Vaccine Sales Growth
5 AMERICAS
5.1 Americas BCG and Tuberculosis Vaccine Sales by Country
5.1.1 Americas BCG and Tuberculosis Vaccine Sales by Country (2019-2024)
5.1.2 Americas BCG and Tuberculosis Vaccine Revenue by Country (2019-2024)
5.2 Americas BCG and Tuberculosis Vaccine Sales by Type
5.3 Americas BCG and Tuberculosis Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC BCG and Tuberculosis Vaccine Sales by Region
6.1.1 APAC BCG and Tuberculosis Vaccine Sales by Region (2019-2024)
6.1.2 APAC BCG and Tuberculosis Vaccine Revenue by Region (2019-2024)
6.2 APAC BCG and Tuberculosis Vaccine Sales by Type
6.3 APAC BCG and Tuberculosis Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe BCG and Tuberculosis Vaccine by Country
7.1.1 Europe BCG and Tuberculosis Vaccine Sales by Country (2019-2024)
7.1.2 Europe BCG and Tuberculosis Vaccine Revenue by Country (2019-2024)
7.2 Europe BCG and Tuberculosis Vaccine Sales by Type
7.3 Europe BCG and Tuberculosis Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa BCG and Tuberculosis Vaccine by Country
8.1.1 Middle East & Africa BCG and Tuberculosis Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa BCG and Tuberculosis Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa BCG and Tuberculosis Vaccine Sales by Type
8.3 Middle East & Africa BCG and Tuberculosis Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of BCG and Tuberculosis Vaccine
10.3 Manufacturing Process Analysis of BCG and Tuberculosis Vaccine
10.4 Industry Chain Structure of BCG and Tuberculosis Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 BCG and Tuberculosis Vaccine Distributors
11.3 BCG and Tuberculosis Vaccine Customer
12 WORLD FORECAST REVIEW FOR BCG AND TUBERCULOSIS VACCINE BY GEOGRAPHIC REGION
12.1 Global BCG and Tuberculosis Vaccine Market Size Forecast by Region
12.1.1 Global BCG and Tuberculosis Vaccine Forecast by Region (2025-2030)
12.1.2 Global BCG and Tuberculosis Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global BCG and Tuberculosis Vaccine Forecast by Type
12.7 Global BCG and Tuberculosis Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.1.3 Merck BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Japan BCG Lab
13.2.1 Japan BCG Lab Company Information
13.2.2 Japan BCG Lab BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.2.3 Japan BCG Lab BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Japan BCG Lab Main Business Overview
13.2.5 Japan BCG Lab Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.3.3 Serum Institute of India BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 AJ Vaccines
13.4.1 AJ Vaccines Company Information
13.4.2 AJ Vaccines BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.4.3 AJ Vaccines BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 AJ Vaccines Main Business Overview
13.4.5 AJ Vaccines Latest Developments
13.5 BioFarma
13.5.1 BioFarma Company Information
13.5.2 BioFarma BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.5.3 BioFarma BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 BioFarma Main Business Overview
13.5.5 BioFarma Latest Developments
13.6 GreenSignal Bio Pharma
13.6.1 GreenSignal Bio Pharma Company Information
13.6.2 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.6.3 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 GreenSignal Bio Pharma Main Business Overview
13.6.5 GreenSignal Bio Pharma Latest Developments
13.7 China National Biotec
13.7.1 China National Biotec Company Information
13.7.2 China National Biotec BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.7.3 China National Biotec BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 China National Biotec Main Business Overview
13.7.5 China National Biotec Latest Developments
13.8 Biomed Lublin
13.8.1 Biomed Lublin Company Information
13.8.2 Biomed Lublin BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.8.3 Biomed Lublin BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Biomed Lublin Main Business Overview
13.8.5 Biomed Lublin Latest Developments
13.9 Taj Pharmaceuticals
13.9.1 Taj Pharmaceuticals Company Information
13.9.2 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.9.3 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Taj Pharmaceuticals Main Business Overview
13.9.5 Taj Pharmaceuticals Latest Developments
13.10 Ataulpho de Paiva
13.10.1 Ataulpho de Paiva Company Information
13.10.2 Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.10.3 Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Ataulpho de Paiva Main Business Overview
13.10.5 Ataulpho de Paiva Latest Developments
13.11 IVAC-Institute of Vaccines and Medical Biologicals
13.11.1 IVAC-Institute of Vaccines and Medical Biologicals Company Information
13.11.2 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.11.3 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 IVAC-Institute of Vaccines and Medical Biologicals Main Business Overview
13.11.5 IVAC-Institute of Vaccines and Medical Biologicals Latest Developments
13.12 Queen Saovabha Mem. Inst
13.12.1 Queen Saovabha Mem. Inst Company Information
13.12.2 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.12.3 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Queen Saovabha Mem. Inst Main Business Overview
13.12.5 Queen Saovabha Mem. Inst Latest Developments
13.13 Microgen
13.13.1 Microgen Company Information
13.13.2 Microgen BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.13.3 Microgen BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Microgen Main Business Overview
13.13.5 Microgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global BCG and Tuberculosis Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for BCG and Tuberculosis Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for BCG and Tuberculosis Vaccine by Country/Region, 2019, 2023 & 2030
2.2 BCG and Tuberculosis Vaccine Segment by Type
2.2.1 Immune Vaccine
2.2.2 Therapy Vaccine
2.3 BCG and Tuberculosis Vaccine Sales by Type
2.3.1 Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global BCG and Tuberculosis Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global BCG and Tuberculosis Vaccine Sale Price by Type (2019-2024)
2.4 BCG and Tuberculosis Vaccine Segment by Application
2.4.1 Self-Procurement
2.4.2 UNICEF
2.4.3 Others
2.5 BCG and Tuberculosis Vaccine Sales by Application
2.5.1 Global BCG and Tuberculosis Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global BCG and Tuberculosis Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global BCG and Tuberculosis Vaccine Sale Price by Application (2019-2024)
3 GLOBAL BCG AND TUBERCULOSIS VACCINE BY COMPANY
3.1 Global BCG and Tuberculosis Vaccine Breakdown Data by Company
3.1.1 Global BCG and Tuberculosis Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global BCG and Tuberculosis Vaccine Sales Market Share by Company (2019-2024)
3.2 Global BCG and Tuberculosis Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global BCG and Tuberculosis Vaccine Revenue by Company (2019-2024)
3.2.2 Global BCG and Tuberculosis Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global BCG and Tuberculosis Vaccine Sale Price by Company
3.4 Key Manufacturers BCG and Tuberculosis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers BCG and Tuberculosis Vaccine Product Location Distribution
3.4.2 Players BCG and Tuberculosis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BCG AND TUBERCULOSIS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic BCG and Tuberculosis Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global BCG and Tuberculosis Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global BCG and Tuberculosis Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic BCG and Tuberculosis Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global BCG and Tuberculosis Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global BCG and Tuberculosis Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas BCG and Tuberculosis Vaccine Sales Growth
4.4 APAC BCG and Tuberculosis Vaccine Sales Growth
4.5 Europe BCG and Tuberculosis Vaccine Sales Growth
4.6 Middle East & Africa BCG and Tuberculosis Vaccine Sales Growth
5 AMERICAS
5.1 Americas BCG and Tuberculosis Vaccine Sales by Country
5.1.1 Americas BCG and Tuberculosis Vaccine Sales by Country (2019-2024)
5.1.2 Americas BCG and Tuberculosis Vaccine Revenue by Country (2019-2024)
5.2 Americas BCG and Tuberculosis Vaccine Sales by Type
5.3 Americas BCG and Tuberculosis Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC BCG and Tuberculosis Vaccine Sales by Region
6.1.1 APAC BCG and Tuberculosis Vaccine Sales by Region (2019-2024)
6.1.2 APAC BCG and Tuberculosis Vaccine Revenue by Region (2019-2024)
6.2 APAC BCG and Tuberculosis Vaccine Sales by Type
6.3 APAC BCG and Tuberculosis Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe BCG and Tuberculosis Vaccine by Country
7.1.1 Europe BCG and Tuberculosis Vaccine Sales by Country (2019-2024)
7.1.2 Europe BCG and Tuberculosis Vaccine Revenue by Country (2019-2024)
7.2 Europe BCG and Tuberculosis Vaccine Sales by Type
7.3 Europe BCG and Tuberculosis Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa BCG and Tuberculosis Vaccine by Country
8.1.1 Middle East & Africa BCG and Tuberculosis Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa BCG and Tuberculosis Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa BCG and Tuberculosis Vaccine Sales by Type
8.3 Middle East & Africa BCG and Tuberculosis Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of BCG and Tuberculosis Vaccine
10.3 Manufacturing Process Analysis of BCG and Tuberculosis Vaccine
10.4 Industry Chain Structure of BCG and Tuberculosis Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 BCG and Tuberculosis Vaccine Distributors
11.3 BCG and Tuberculosis Vaccine Customer
12 WORLD FORECAST REVIEW FOR BCG AND TUBERCULOSIS VACCINE BY GEOGRAPHIC REGION
12.1 Global BCG and Tuberculosis Vaccine Market Size Forecast by Region
12.1.1 Global BCG and Tuberculosis Vaccine Forecast by Region (2025-2030)
12.1.2 Global BCG and Tuberculosis Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global BCG and Tuberculosis Vaccine Forecast by Type
12.7 Global BCG and Tuberculosis Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.1.3 Merck BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Japan BCG Lab
13.2.1 Japan BCG Lab Company Information
13.2.2 Japan BCG Lab BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.2.3 Japan BCG Lab BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Japan BCG Lab Main Business Overview
13.2.5 Japan BCG Lab Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.3.3 Serum Institute of India BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 AJ Vaccines
13.4.1 AJ Vaccines Company Information
13.4.2 AJ Vaccines BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.4.3 AJ Vaccines BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 AJ Vaccines Main Business Overview
13.4.5 AJ Vaccines Latest Developments
13.5 BioFarma
13.5.1 BioFarma Company Information
13.5.2 BioFarma BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.5.3 BioFarma BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 BioFarma Main Business Overview
13.5.5 BioFarma Latest Developments
13.6 GreenSignal Bio Pharma
13.6.1 GreenSignal Bio Pharma Company Information
13.6.2 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.6.3 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 GreenSignal Bio Pharma Main Business Overview
13.6.5 GreenSignal Bio Pharma Latest Developments
13.7 China National Biotec
13.7.1 China National Biotec Company Information
13.7.2 China National Biotec BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.7.3 China National Biotec BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 China National Biotec Main Business Overview
13.7.5 China National Biotec Latest Developments
13.8 Biomed Lublin
13.8.1 Biomed Lublin Company Information
13.8.2 Biomed Lublin BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.8.3 Biomed Lublin BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Biomed Lublin Main Business Overview
13.8.5 Biomed Lublin Latest Developments
13.9 Taj Pharmaceuticals
13.9.1 Taj Pharmaceuticals Company Information
13.9.2 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.9.3 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Taj Pharmaceuticals Main Business Overview
13.9.5 Taj Pharmaceuticals Latest Developments
13.10 Ataulpho de Paiva
13.10.1 Ataulpho de Paiva Company Information
13.10.2 Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.10.3 Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Ataulpho de Paiva Main Business Overview
13.10.5 Ataulpho de Paiva Latest Developments
13.11 IVAC-Institute of Vaccines and Medical Biologicals
13.11.1 IVAC-Institute of Vaccines and Medical Biologicals Company Information
13.11.2 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.11.3 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 IVAC-Institute of Vaccines and Medical Biologicals Main Business Overview
13.11.5 IVAC-Institute of Vaccines and Medical Biologicals Latest Developments
13.12 Queen Saovabha Mem. Inst
13.12.1 Queen Saovabha Mem. Inst Company Information
13.12.2 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.12.3 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Queen Saovabha Mem. Inst Main Business Overview
13.12.5 Queen Saovabha Mem. Inst Latest Developments
13.13 Microgen
13.13.1 Microgen Company Information
13.13.2 Microgen BCG and Tuberculosis Vaccine Product Portfolios and Specifications
13.13.3 Microgen BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Microgen Main Business Overview
13.13.5 Microgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. BCG and Tuberculosis Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. BCG and Tuberculosis Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Immune Vaccine
Table 4. Major Players of Therapy Vaccine
Table 5. Global BCG and Tuberculosis Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global BCG and Tuberculosis Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global BCG and Tuberculosis Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global BCG and Tuberculosis Vaccine Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global BCG and Tuberculosis Vaccine Sales by Application (2019-2024) & (K Units)
Table 11. Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global BCG and Tuberculosis Vaccine Revenue by Application (2019-2024)
Table 13. Global BCG and Tuberculosis Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global BCG and Tuberculosis Vaccine Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global BCG and Tuberculosis Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global BCG and Tuberculosis Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global BCG and Tuberculosis Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global BCG and Tuberculosis Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global BCG and Tuberculosis Vaccine Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers BCG and Tuberculosis Vaccine Producing Area Distribution and Sales Area
Table 21. Players BCG and Tuberculosis Vaccine Products Offered
Table 22. BCG and Tuberculosis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global BCG and Tuberculosis Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global BCG and Tuberculosis Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global BCG and Tuberculosis Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global BCG and Tuberculosis Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global BCG and Tuberculosis Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global BCG and Tuberculosis Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global BCG and Tuberculosis Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global BCG and Tuberculosis Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas BCG and Tuberculosis Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas BCG and Tuberculosis Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas BCG and Tuberculosis Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas BCG and Tuberculosis Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas BCG and Tuberculosis Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas BCG and Tuberculosis Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC BCG and Tuberculosis Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC BCG and Tuberculosis Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC BCG and Tuberculosis Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC BCG and Tuberculosis Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC BCG and Tuberculosis Vaccine Sales by Type (2019-2024) & (K Units)
Table 44. APAC BCG and Tuberculosis Vaccine Sales by Application (2019-2024) & (K Units)
Table 45. Europe BCG and Tuberculosis Vaccine Sales by Country (2019-2024) & (K Units)
Table 46. Europe BCG and Tuberculosis Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe BCG and Tuberculosis Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe BCG and Tuberculosis Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe BCG and Tuberculosis Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Europe BCG and Tuberculosis Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa BCG and Tuberculosis Vaccine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa BCG and Tuberculosis Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa BCG and Tuberculosis Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa BCG and Tuberculosis Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa BCG and Tuberculosis Vaccine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa BCG and Tuberculosis Vaccine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of BCG and Tuberculosis Vaccine
Table 58. Key Market Challenges & Risks of BCG and Tuberculosis Vaccine
Table 59. Key Industry Trends of BCG and Tuberculosis Vaccine
Table 60. BCG and Tuberculosis Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. BCG and Tuberculosis Vaccine Distributors List
Table 63. BCG and Tuberculosis Vaccine Customer List
Table 64. Global BCG and Tuberculosis Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global BCG and Tuberculosis Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas BCG and Tuberculosis Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas BCG and Tuberculosis Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC BCG and Tuberculosis Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC BCG and Tuberculosis Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe BCG and Tuberculosis Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe BCG and Tuberculosis Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa BCG and Tuberculosis Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa BCG and Tuberculosis Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global BCG and Tuberculosis Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global BCG and Tuberculosis Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global BCG and Tuberculosis Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global BCG and Tuberculosis Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Merck Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 80. Merck BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Japan BCG Lab Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Japan BCG Lab BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 85. Japan BCG Lab BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Japan BCG Lab Main Business
Table 87. Japan BCG Lab Latest Developments
Table 88. Serum Institute of India Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Serum Institute of India BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 90. Serum Institute of India BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Serum Institute of India Main Business
Table 92. Serum Institute of India Latest Developments
Table 93. AJ Vaccines Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. AJ Vaccines BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 95. AJ Vaccines BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. AJ Vaccines Main Business
Table 97. AJ Vaccines Latest Developments
Table 98. BioFarma Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. BioFarma BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 100. BioFarma BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. BioFarma Main Business
Table 102. BioFarma Latest Developments
Table 103. GreenSignal Bio Pharma Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 105. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. GreenSignal Bio Pharma Main Business
Table 107. GreenSignal Bio Pharma Latest Developments
Table 108. China National Biotec Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. China National Biotec BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 110. China National Biotec BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. China National Biotec Main Business
Table 112. China National Biotec Latest Developments
Table 113. Biomed Lublin Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Biomed Lublin BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 115. Biomed Lublin BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Biomed Lublin Main Business
Table 117. Biomed Lublin Latest Developments
Table 118. Taj Pharmaceuticals Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 120. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Taj Pharmaceuticals Main Business
Table 122. Taj Pharmaceuticals Latest Developments
Table 123. Ataulpho de Paiva Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 125. Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Ataulpho de Paiva Main Business
Table 127. Ataulpho de Paiva Latest Developments
Table 128. IVAC-Institute of Vaccines and Medical Biologicals Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 130. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. IVAC-Institute of Vaccines and Medical Biologicals Main Business
Table 132. IVAC-Institute of Vaccines and Medical Biologicals Latest Developments
Table 133. Queen Saovabha Mem. Inst Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 135. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Queen Saovabha Mem. Inst Main Business
Table 137. Queen Saovabha Mem. Inst Latest Developments
Table 138. Microgen Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Microgen BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 140. Microgen BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. Microgen Main Business
Table 142. Microgen Latest Developments
Table 1. BCG and Tuberculosis Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. BCG and Tuberculosis Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Immune Vaccine
Table 4. Major Players of Therapy Vaccine
Table 5. Global BCG and Tuberculosis Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global BCG and Tuberculosis Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global BCG and Tuberculosis Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global BCG and Tuberculosis Vaccine Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global BCG and Tuberculosis Vaccine Sales by Application (2019-2024) & (K Units)
Table 11. Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global BCG and Tuberculosis Vaccine Revenue by Application (2019-2024)
Table 13. Global BCG and Tuberculosis Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global BCG and Tuberculosis Vaccine Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global BCG and Tuberculosis Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global BCG and Tuberculosis Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global BCG and Tuberculosis Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global BCG and Tuberculosis Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global BCG and Tuberculosis Vaccine Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers BCG and Tuberculosis Vaccine Producing Area Distribution and Sales Area
Table 21. Players BCG and Tuberculosis Vaccine Products Offered
Table 22. BCG and Tuberculosis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global BCG and Tuberculosis Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global BCG and Tuberculosis Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global BCG and Tuberculosis Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global BCG and Tuberculosis Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global BCG and Tuberculosis Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global BCG and Tuberculosis Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global BCG and Tuberculosis Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global BCG and Tuberculosis Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas BCG and Tuberculosis Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas BCG and Tuberculosis Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas BCG and Tuberculosis Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas BCG and Tuberculosis Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas BCG and Tuberculosis Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas BCG and Tuberculosis Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC BCG and Tuberculosis Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC BCG and Tuberculosis Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC BCG and Tuberculosis Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC BCG and Tuberculosis Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC BCG and Tuberculosis Vaccine Sales by Type (2019-2024) & (K Units)
Table 44. APAC BCG and Tuberculosis Vaccine Sales by Application (2019-2024) & (K Units)
Table 45. Europe BCG and Tuberculosis Vaccine Sales by Country (2019-2024) & (K Units)
Table 46. Europe BCG and Tuberculosis Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe BCG and Tuberculosis Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe BCG and Tuberculosis Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe BCG and Tuberculosis Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Europe BCG and Tuberculosis Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa BCG and Tuberculosis Vaccine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa BCG and Tuberculosis Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa BCG and Tuberculosis Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa BCG and Tuberculosis Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa BCG and Tuberculosis Vaccine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa BCG and Tuberculosis Vaccine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of BCG and Tuberculosis Vaccine
Table 58. Key Market Challenges & Risks of BCG and Tuberculosis Vaccine
Table 59. Key Industry Trends of BCG and Tuberculosis Vaccine
Table 60. BCG and Tuberculosis Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. BCG and Tuberculosis Vaccine Distributors List
Table 63. BCG and Tuberculosis Vaccine Customer List
Table 64. Global BCG and Tuberculosis Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global BCG and Tuberculosis Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas BCG and Tuberculosis Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas BCG and Tuberculosis Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC BCG and Tuberculosis Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC BCG and Tuberculosis Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe BCG and Tuberculosis Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe BCG and Tuberculosis Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa BCG and Tuberculosis Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa BCG and Tuberculosis Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global BCG and Tuberculosis Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global BCG and Tuberculosis Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global BCG and Tuberculosis Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global BCG and Tuberculosis Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Merck Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 80. Merck BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Japan BCG Lab Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Japan BCG Lab BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 85. Japan BCG Lab BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Japan BCG Lab Main Business
Table 87. Japan BCG Lab Latest Developments
Table 88. Serum Institute of India Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Serum Institute of India BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 90. Serum Institute of India BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Serum Institute of India Main Business
Table 92. Serum Institute of India Latest Developments
Table 93. AJ Vaccines Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. AJ Vaccines BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 95. AJ Vaccines BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. AJ Vaccines Main Business
Table 97. AJ Vaccines Latest Developments
Table 98. BioFarma Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. BioFarma BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 100. BioFarma BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. BioFarma Main Business
Table 102. BioFarma Latest Developments
Table 103. GreenSignal Bio Pharma Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 105. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. GreenSignal Bio Pharma Main Business
Table 107. GreenSignal Bio Pharma Latest Developments
Table 108. China National Biotec Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. China National Biotec BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 110. China National Biotec BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. China National Biotec Main Business
Table 112. China National Biotec Latest Developments
Table 113. Biomed Lublin Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Biomed Lublin BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 115. Biomed Lublin BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Biomed Lublin Main Business
Table 117. Biomed Lublin Latest Developments
Table 118. Taj Pharmaceuticals Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 120. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Taj Pharmaceuticals Main Business
Table 122. Taj Pharmaceuticals Latest Developments
Table 123. Ataulpho de Paiva Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 125. Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Ataulpho de Paiva Main Business
Table 127. Ataulpho de Paiva Latest Developments
Table 128. IVAC-Institute of Vaccines and Medical Biologicals Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 130. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. IVAC-Institute of Vaccines and Medical Biologicals Main Business
Table 132. IVAC-Institute of Vaccines and Medical Biologicals Latest Developments
Table 133. Queen Saovabha Mem. Inst Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 135. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Queen Saovabha Mem. Inst Main Business
Table 137. Queen Saovabha Mem. Inst Latest Developments
Table 138. Microgen Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Microgen BCG and Tuberculosis Vaccine Product Portfolios and Specifications
Table 140. Microgen BCG and Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. Microgen Main Business
Table 142. Microgen Latest Developments
LIST OF FIGURES
Figure 1. Picture of BCG and Tuberculosis Vaccine
Figure 2. BCG and Tuberculosis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global BCG and Tuberculosis Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global BCG and Tuberculosis Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. BCG and Tuberculosis Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Immune Vaccine
Figure 10. Product Picture of Therapy Vaccine
Figure 11. Global BCG and Tuberculosis Vaccine Sales Market Share by Type in 2023
Figure 12. Global BCG and Tuberculosis Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. BCG and Tuberculosis Vaccine Consumed in Self-Procurement
Figure 14. Global BCG and Tuberculosis Vaccine Market: Self-Procurement (2019-2024) & (K Units)
Figure 15. BCG and Tuberculosis Vaccine Consumed in UNICEF
Figure 16. Global BCG and Tuberculosis Vaccine Market: UNICEF (2019-2024) & (K Units)
Figure 17. BCG and Tuberculosis Vaccine Consumed in Others
Figure 18. Global BCG and Tuberculosis Vaccine Market: Others (2019-2024) & (K Units)
Figure 19. Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2023)
Figure 20. Global BCG and Tuberculosis Vaccine Revenue Market Share by Application in 2023
Figure 21. BCG and Tuberculosis Vaccine Sales Market by Company in 2023 (K Units)
Figure 22. Global BCG and Tuberculosis Vaccine Sales Market Share by Company in 2023
Figure 23. BCG and Tuberculosis Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global BCG and Tuberculosis Vaccine Revenue Market Share by Company in 2023
Figure 25. Global BCG and Tuberculosis Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global BCG and Tuberculosis Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas BCG and Tuberculosis Vaccine Sales 2019-2024 (K Units)
Figure 28. Americas BCG and Tuberculosis Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. APAC BCG and Tuberculosis Vaccine Sales 2019-2024 (K Units)
Figure 30. APAC BCG and Tuberculosis Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Europe BCG and Tuberculosis Vaccine Sales 2019-2024 (K Units)
Figure 32. Europe BCG and Tuberculosis Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa BCG and Tuberculosis Vaccine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa BCG and Tuberculosis Vaccine Revenue 2019-2024 ($ Millions)
Figure 35. Americas BCG and Tuberculosis Vaccine Sales Market Share by Country in 2023
Figure 36. Americas BCG and Tuberculosis Vaccine Revenue Market Share by Country in 2023
Figure 37. Americas BCG and Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas BCG and Tuberculosis Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC BCG and Tuberculosis Vaccine Sales Market Share by Region in 2023
Figure 44. APAC BCG and Tuberculosis Vaccine Revenue Market Share by Regions in 2023
Figure 45. APAC BCG and Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC BCG and Tuberculosis Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe BCG and Tuberculosis Vaccine Sales Market Share by Country in 2023
Figure 55. Europe BCG and Tuberculosis Vaccine Revenue Market Share by Country in 2023
Figure 56. Europe BCG and Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe BCG and Tuberculosis Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa BCG and Tuberculosis Vaccine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa BCG and Tuberculosis Vaccine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa BCG and Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa BCG and Tuberculosis Vaccine Sales Market Share by Application (2019-2024)
Figure 67. Egypt BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of BCG and Tuberculosis Vaccine in 2023
Figure 73. Manufacturing Process Analysis of BCG and Tuberculosis Vaccine
Figure 74. Industry Chain Structure of BCG and Tuberculosis Vaccine
Figure 75. Channels of Distribution
Figure 76. Global BCG and Tuberculosis Vaccine Sales Market Forecast by Region (2025-2030)
Figure 77. Global BCG and Tuberculosis Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global BCG and Tuberculosis Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global BCG and Tuberculosis Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global BCG and Tuberculosis Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global BCG and Tuberculosis Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of BCG and Tuberculosis Vaccine
Figure 2. BCG and Tuberculosis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global BCG and Tuberculosis Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global BCG and Tuberculosis Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. BCG and Tuberculosis Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Immune Vaccine
Figure 10. Product Picture of Therapy Vaccine
Figure 11. Global BCG and Tuberculosis Vaccine Sales Market Share by Type in 2023
Figure 12. Global BCG and Tuberculosis Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. BCG and Tuberculosis Vaccine Consumed in Self-Procurement
Figure 14. Global BCG and Tuberculosis Vaccine Market: Self-Procurement (2019-2024) & (K Units)
Figure 15. BCG and Tuberculosis Vaccine Consumed in UNICEF
Figure 16. Global BCG and Tuberculosis Vaccine Market: UNICEF (2019-2024) & (K Units)
Figure 17. BCG and Tuberculosis Vaccine Consumed in Others
Figure 18. Global BCG and Tuberculosis Vaccine Market: Others (2019-2024) & (K Units)
Figure 19. Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2023)
Figure 20. Global BCG and Tuberculosis Vaccine Revenue Market Share by Application in 2023
Figure 21. BCG and Tuberculosis Vaccine Sales Market by Company in 2023 (K Units)
Figure 22. Global BCG and Tuberculosis Vaccine Sales Market Share by Company in 2023
Figure 23. BCG and Tuberculosis Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global BCG and Tuberculosis Vaccine Revenue Market Share by Company in 2023
Figure 25. Global BCG and Tuberculosis Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global BCG and Tuberculosis Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas BCG and Tuberculosis Vaccine Sales 2019-2024 (K Units)
Figure 28. Americas BCG and Tuberculosis Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. APAC BCG and Tuberculosis Vaccine Sales 2019-2024 (K Units)
Figure 30. APAC BCG and Tuberculosis Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Europe BCG and Tuberculosis Vaccine Sales 2019-2024 (K Units)
Figure 32. Europe BCG and Tuberculosis Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa BCG and Tuberculosis Vaccine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa BCG and Tuberculosis Vaccine Revenue 2019-2024 ($ Millions)
Figure 35. Americas BCG and Tuberculosis Vaccine Sales Market Share by Country in 2023
Figure 36. Americas BCG and Tuberculosis Vaccine Revenue Market Share by Country in 2023
Figure 37. Americas BCG and Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas BCG and Tuberculosis Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC BCG and Tuberculosis Vaccine Sales Market Share by Region in 2023
Figure 44. APAC BCG and Tuberculosis Vaccine Revenue Market Share by Regions in 2023
Figure 45. APAC BCG and Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC BCG and Tuberculosis Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe BCG and Tuberculosis Vaccine Sales Market Share by Country in 2023
Figure 55. Europe BCG and Tuberculosis Vaccine Revenue Market Share by Country in 2023
Figure 56. Europe BCG and Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe BCG and Tuberculosis Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa BCG and Tuberculosis Vaccine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa BCG and Tuberculosis Vaccine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa BCG and Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa BCG and Tuberculosis Vaccine Sales Market Share by Application (2019-2024)
Figure 67. Egypt BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country BCG and Tuberculosis Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of BCG and Tuberculosis Vaccine in 2023
Figure 73. Manufacturing Process Analysis of BCG and Tuberculosis Vaccine
Figure 74. Industry Chain Structure of BCG and Tuberculosis Vaccine
Figure 75. Channels of Distribution
Figure 76. Global BCG and Tuberculosis Vaccine Sales Market Forecast by Region (2025-2030)
Figure 77. Global BCG and Tuberculosis Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global BCG and Tuberculosis Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global BCG and Tuberculosis Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global BCG and Tuberculosis Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global BCG and Tuberculosis Vaccine Revenue Market Share Forecast by Application (2025-2030)
